A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD7022

Hyperlipemia Clinical Trial

Official title:
A Randomized, Single Blind, Placebo Controlled, Single Center Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of Subcutaneously Administered RBD7022 in Participants With Normal or Elevated LDL-c Cholesterol

Status Recruiting

Clinical Trial Summary

This is a randomized, single blind, placebo controlled, single center phase I study to evaluate the safety, tolerability, pharmacokinetics, and preliminary pharmacodynamics of single and multiple ascending doses of subcutaneously administered RBD7022 in participants with normal or elevated LDL-c cholesterol. The study will be performed in 2 phases: single ascending dose (SAD) phase and multiple ascending doses (MAD) phase in participants. The decision to escalate to subsequent dose levels will be made by the SRC based on the review of all available safety information in each cohort.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05912296
Study type	Interventional
Source	Suzhou Ribo Life Science Co. Ltd.
Contact	Rui Chen, Doctor
Phone	86 010 69154794
Email	chenrui04@126.com
Status	Recruiting
Phase	Phase 1
Start date	May 17, 2023
Completion date	March 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04382521` - A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions	N/A
Not yet recruiting	`NCT02593487` - Effect of Rosuvastatin Therapy on HDL2 Level	Phase 4
Active, not recruiting	`NCT02697422` - Veteran Peer Coaches Optimizing and Advancing Cardiac Health	N/A
Completed	`NCT04469673` - A Study to Evaluate the Safety, Tolerability and Efficacy of Multiple Doses of JS002 in Patients With Hyperlipidemia..	Phase 1/Phase 2
Active, not recruiting	`NCT05432544` - Safety and Tolerability of SHR-1918 in Healthy Subjects	Phase 1
Completed	`NCT03950752` - Effect of Consumption of Bagel Without Palm Oil on Postprandial Lipidemia	N/A
Not yet recruiting	`NCT06229548` - A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2053	Phase 1
Completed	`NCT05532800` - The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia	Phase 3
Completed	`NCT04781114` - The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia	Phase 3
Active, not recruiting	`NCT04515927` - To Evaluate the Efficacy and Safety of JS002 in HoFH Patients	Phase 2